Gut	O
Microbiota	O
Promote	O
Angiotensin	B:C0003009
II	I:C0003009
-	O
Induced	O
Arterial	B:C0020538
Hypertension	I:C0020538
and	O
Vascular	B:C0856169
Dysfunction	I:C0856169
.	O

The	O
gut	O
microbiome	O
is	O
essential	O
for	O
physiological	O
host	B:C0301872
responses	I:C0301872
and	O
development	O
of	O
immune	B:C1817756
functions	I:C1817756
.	O

The	O
impact	O
of	O
gut	O
microbiota	O
on	O
blood	B:C0005823
pressure	I:C0005823
and	O
systemic	O
vascular	B:C0232337
function	I:C0232337
,	O
processes	O
that	O
are	O
determined	O
by	O
immune	O
cell	B:C0007613
function	I:C0007613
,	O
is	O
unknown	O
.	O

Unchallenged	O
germ	O
-	O
free	O
mice	B:C0025929
(	O
GF	O
)	O
had	O
a	O
dampened	O
systemic	O
T	B:C0242632
helper	I:C0242632
cell	I:C0242632
type	I:C0242632
1	I:C0242632
skewing	B:C0271381
compared	O
to	O
conventionally	O
raised	O
(	O
CONV	O
-	O
R	O
)	O
mice	B:C0025929
.	O

Colonization	B:C4289767
of	O
GF	O
mice	B:C0025929
with	O
regular	O
gut	O
microbiota	O
induced	O
lymphoid	B:C0086574
mRNA	B:C1158816
transcription	I:C1158816
of	O
T	B:C0752212
-	I:C0752212
box	I:C0752212
expression	B:C1171362
in	O
T	B:C0039194
cells	I:C0039194
and	O
resulted	O
in	O
mild	O
endothelial	B:C0856169
dysfunction	I:C0856169
.	O

Compared	O
to	O
CONV-R	O
mice	B:C0025929
,	O
angiotensin	B:C0003009
II	I:C0003009
(	O
angiotensin	B:C0003009
II	I:C0003009
;	O
1	O
mg	O
/	O
kg	O
per	O
day	O
for	O
7	O
days	O
)	O
infused	O
GF	O
mice	B:C0025929
showed	O
reduced	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
formation	O
in	O
the	O
vasculature	B:C3714653
,	O
attenuated	O
vascular	B:C0005847
mRNA	B:C1515670
expression	I:C1515670
of	O
monocyte	B:C1337092
chemoattractant	I:C1337092
protein	I:C1337092
1	I:C1337092
(	O
monocyte	B:C0128897
chemoattractant	I:C0128897
protein	I:C0128897
1	I:C0128897
)	O
,	O
inducible	B:C1417760
nitric	I:C1417760
oxide	I:C1417760
synthase	I:C1417760
(	O
inducible	B:C1417760
nitric	I:C1417760
oxide	I:C1417760
synthase	I:C1417760
)	O
and	O
NADPH	B:C1413844
oxidase	I:C1413844
subunit	I:C1413844
Nox2	I:C1413844
,	O
as	O
well	O
as	O
a	O
reduced	O
upregulation	B:C0949479
of	O
retinoic	B:C2717992
-	I:C2717992
acid	I:C2717992
receptor	I:C2717992
-	I:C2717992
related	I:C2717992
orphan	I:C2717992
receptor	I:C2717992
gamma	I:C2717992
t	I:C2717992
(	O
receptor	B:C2717992
-	I:C2717992
related	I:C2717992
orphan	I:C2717992
receptor	I:C2717992
gamma	I:C2717992
t	I:C2717992
)	O
,	O
the	O
signature	O
transcription	B:C0040648
factor	I:C0040648
for	O
interleukin	B:C0384648
(	I:C0384648
IL	I:C0384648
)	I:C0384648
-	I:C0384648
17	I:C0384648
synthesis	O
.	O

This	O
resulted	O
in	O
an	O
attenuated	O
vascular	B:C4236809
leukocyte	I:C4236809
adhesion	I:C4236809
,	O
less	O
infiltration	B:C0332448
of	O
Ly6G	B:C1433476
(+	I:C1433476
)	I:C1433476
neutrophils	B:C0027950
and	O
Ly6C	B:C1530208
(+	I:C1530208
)	I:C1530208
monocytes	B:C0026473
into	O
the	O
aortic	B:C0507851
vessel	I:C0507851
wall	I:C0507851
,	O
protection	O
from	O
kidney	B:C0027697
inflammation	I:C0027697
,	O
as	O
well	O
as	O
endothelial	B:C0856169
dysfunction	I:C0856169
and	O
attenuation	O
of	O
blood	B:C0497247
pressure	I:C0497247
increase	I:C0497247
in	O
response	O
to	O
angiotensin	B:C0003009
II	I:C0003009
.	O

Importantly	O
,	O
cardiac	O
inflammation	O
,	O
fibrosis	B:C0016059
and	O
systolic	B:C0749225
dysfunction	I:C0749225
were	O
attenuated	O
in	O
GF	O
mice	B:C0025929
,	O
indicating	O
systemic	O
protection	O
from	O
cardiovascular	B:C0038435
inflammatory	I:C0038435
stress	I:C0038435
induced	O
by	O
angiotensin	B:C0003009
II	I:C0003009
.	O

Gut	O
microbiota	O
facilitate	O
angiotensin	B:C0003009
II	I:C0003009
-	O
induced	O
vascular	B:C0856169
dysfunction	I:C0856169
and	O
hypertension	B:C0020538
,	O
at	O
least	O
in	O
part	O
,	O
by	O
supporting	O
an	O
monocyte	B:C0128897
chemoattractant	I:C0128897
protein	I:C0128897
1	I:C0128897
/	O
IL	B:C0384648
-	I:C0384648
17	I:C0384648
driven	O
vascular	B:C0005847
immune	B:C0312740
cell	I:C0312740
infiltration	B:C0332448
and	O
inflammation	B:C0021368
.	O

